IRWINDALE, CA – November 28, 2010 – GeneFluidics, Inc., a biotech company that designs, markets and manufactures automated testing equipment based on proprietary electrochemical-based molecular analysis and an advanced engineering platform, today announced that it has received ISO 9001:2008 certification, an internationally recognized quality system standard for continual improvement to process performance.
The ISO 9001:2008 certification covers the design, development, manufacturing, sales and service of GeneFluidics’ electrochemical sensor chips and reader platform. This certification demonstrates that GeneFluidics has a quality management system in place to ensure consistency and improvement of processes, leading to high levels of performance and customer satisfaction. Certified organizations are committed to continuous improvement and are re-assessed annually to ensure progress is being maintained.
“We are pleased to have achieved ISO 9001 certification as it underscores GeneFluidics’ commitment to our customers and focus on quality and continual improvement,” said Vincent Gau, CEO and President of GeneFluidics, Inc.
The ISO (International Organization for Standardization) is the world’s largest developer and publisher of international standards. GeneFluidics’ ISO 9001:2008 certificate was awarded by NSF International.
About GeneFluidics
GeneFluidics was incorporated in 2000 to develop a fast, accurate, and simple testing system for improving worldwide health. By integrating novel bionano electrochemical technologies, the company’s revolutionary sensor platform enables bioassays to be performed in under an hour with sensitivity to picogram/ml concentrations for immunoassays and femtomolar concentrations for genetic assays, without the use of PCR.
For more information on GeneFluidics, contact:
Vincent Gau, President/CEO
845 Meridian Street, Irwindale, CA 91010
Phone: 626 263-3060
Email: info@genefluidics-lifescience.com